REQUEST A DEMO
Total
USD $0.00
Search more companies

C.I. Medinal Limitada (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: C.I. Medinal Limitada Profile Updated: June 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

C.I. Medinal Limitada is based in Colombia. The head office is in Cali. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on December 12, 2001. It currently has a total number of 5 (2024) employees. From the latest financial highlights, C.I. Medinal Limitada reported a net sales revenue increase of 11.01% in 2023. Its’ total assets recorded a negative growth of 4.83%. The net profit margin of C.I. Medinal Limitada increased by 9.09% in 2023.

Headquarters
Kr 17 C # 41 - 51
Cali; Valle del Cauca;

Contact Details: Purchase the C.I. Medinal Limitada report to view the information.

Basic Information
Total Employees:
Purchase the C.I. Medinal Limitada report to view the information.
Outstanding Shares:
Purchase the C.I. Medinal Limitada report to view the information.
Incorporation Date:
December 12, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after C.I. Medinal Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.01%
Total operating revenue
11.01%
Operating profit (EBIT)
170.8%
Net Profit (Loss) for the Period
215.2%
Total assets
-4.83%
Total equity
35.98%
Operating Profit Margin (ROS)
9.41%
Net Profit Margin
9.09%
Return on Equity (ROE)
17%
Quick Ratio
0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?